8:00am – 8:55am

Breakfast

8:55am – 9:00am

Gerson Lehrman Group Opening Remarks

9:00am – 9:05am

Argyle Executive Forum Opening Remarks

9:05am - 9:45am

Panel Discussion

"Deal Making in Pharmaceuticals and Biotechnology"

Session topics include, but are not limited to:

• Investment trends in pharma and biotech
• Important developments in 2010 and their impact on the industry as a whole
• Responding to changes in the market
• Due diligence- how do you conduct your due diligence on deals?
• Discussion on the M&A environment – is the market poised for a return on investments?

Moderator:
Shannon Pettypiece
Reporter
Bloomberg Television

Panelists:
Anne Altmeyer, PhD, MBA, MPH
Executive Director, Business Development & Licensing, Oncology
Novartis Pharmaceuticals Corporation

Milton H. Grannatt, Ph.D.
Vice President & Head, Negotiations, Respiratory & New Growth Opportunities Global Business Development & Licensing
Novartis Pharmaceuticals Corporation

Richard Hoyt
Vice President Asset and Portfolio Management
Covidien Pharmaceuticals

Don Urbanowicz
Vice President, Business Development
Stryker Corporation

*This session is off the record

9:50am – 10:30am

Panel Discussion

"Opportunities and Challenges for Deal Making in Emerging Markets and Abroad"

Session topics include, but are not limited to:

• As developing countries mature, they will require extensive pharmaceutical and healthcare development and investment. Thoughts on opportunities cross border and abroad? 
• Best practices for investing and partnering with companies internationally- what you need to know before putting time and money into international investments
• Risk v. value of investing in internationally? What types of investments have the most risk? What do you think have the least? What types do you predict to have the most ROI?
• Case studies

Moderator:
Kiva S. Kolstein
Vice President
Gerson Lehrman Group

Panelists:
Barbara J. Dalton, Ph.D.
Vice President, Pfizer Ventures Investments - Worldwide Business Development
Pfizer

Rita Kelley
Managing Director, Kelley & Associates
Former Senior Director, Millennium Pharmaceuticals

David Nicholson, PhD
Senior Vice President and Head Worldwide Licensing and Knowledge Management
Merck Research Laboratories

10:35am – 11:15am

Panel Discussion

"Strategic Alliances and Joint Ventures"

Session topics include, but are not limited to:

• Discussion on how strategic alliances and joint ventures have become part of your overall business development strategy
• Strategic partnering to improve R&D
• How have pharma commercial models responded to the patent cliff?
  • Downsizing?
  • Reorganizing?
  • Shifted focus to highly specialist markets

Moderator:
Shannon Pettypiece
Reporter
Bloomberg Television

Panelists:
Sheila Dell, Ph.D
Vice President, Business Development
Catalent Pharma Solutions

Pamela Demain
Executive Director, Corporate Licensing
Merck & Co., Inc.

Sam Rasty, Ph.D., MBA
Director, Corporate Development
Endo Pharmaceuticals, Inc.

11:15am – 11:30am

Closing Remarks and Networking Coffee Reception

*Please note agenda is subject to change.